I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Privolnev, Y
22
results:
Search for persons
X
Sorted by: Relevance
Sorted by: Year
?
1
EE109 BoNT-As for Adult Upper Limb Spasticity: Cost of Trea..:
Privolnev, Y
;
Johnston, K
;
Griffin, E
Value in Health. 27 (2024) 6 - p. S77 , 2024
Link:
https://doi.org/10.1016/..
?
2
HTA65 How Does Conditional Regulatory Approval Affect the R..:
Privolnev, Y
;
Liovas, A
;
Chan, L
Value in Health. 27 (2024) 6 - p. S256 , 2024
Link:
https://doi.org/10.1016/..
?
3
EE46 BoNT-As for Cervical Dystonia: Cost of Treatment and R..:
Johnston, K.
;
Griffin, E.
;
Privolnev, Y.
Value in Health. 26 (2023) 12 - p. S58 , 2023
Link:
https://doi.org/10.1016/..
?
4
HTA43 Do Complexities of Combination Oncology Submissions I..:
Liovas, A.
;
Privolnev, Y.
;
Pan, V.
.
Value in Health. 26 (2023) 6 - p. S266 , 2023
Link:
https://doi.org/10.1016/..
?
5
HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiatio..:
Privolnev, Y
;
Liovas, A
;
Jakac-Sinclair, N
Value in Health. 25 (2022) 12 - p. S336 , 2022
Link:
https://doi.org/10.1016/..
?
6
PBI47 PAYER AND PRESCRIBER PERSPECTIVES ON CHIMERIC ANTIGEN..:
Privolnev, Y.
;
Vinuesa, L.
Value in Health. 22 (2019) - p. S425 , 2019
Link:
https://doi.org/10.1016/..
?
7
PDB80 DIABETIC MACULAR EDEMA IN EUROPE: THE IMPACT OF PAYER..:
Privolnev, Y.
;
Cox, J.
;
McFadden, E.
.
Value in Health. 22 (2019) - p. S587 , 2019
Link:
https://doi.org/10.1016/..
?
8
PBI26 SINK OR SWIM: HOW CAN SLE BIOLOGICS SUCCESSFULLY ACHI..:
Privolnev, Y.
;
Albacker, C.
;
Nasa, M.
Value in Health. 22 (2019) - p. S51-S52 , 2019
Link:
https://doi.org/10.1016/..
?
9
PGI42 THE NEW WAVE OF ULCERATIVE COLITIS BIOLOGICS: CONSTRA..:
Privolnev, Y.
;
Kravit, A.
;
Duarte, H.
.
Value in Health. 22 (2019) - p. S623 , 2019
Link:
https://doi.org/10.1016/..
?
10
PCN355 DO PAYER AND PRESCRIBER ENDPOINT PREFERENCES ALIGN?:..:
Privolnev, Y.
;
Adler, B.
Value in Health. 22 (2019) - p. S505 , 2019
Link:
https://doi.org/10.1016/..
?
11
PRO88 PAYER AND PHYSICIAN PERSPECTIVES OF CURRENT AND EMERG..:
Privolnev, Y.
;
Duarte, H.
;
Saini, A.
Value in Health. 22 (2019) - p. S857 , 2019
Link:
https://doi.org/10.1016/..
?
12
PHP181 - HEALTH TECHNOLOGY ASSESSMENT OF ONCOLOGY THERAPIES..:
Privolnev, Y.
;
Moore, R.
;
Sharma, K.
Value in Health. 21 (2018) - p. S180 , 2018
Link:
https://doi.org/10.1016/..
?
13
PSY137 - ORPHAN DRUG ACCESS AND REIMBURSEMENT IN THE EU5: C..:
Privolnev, Y.
;
Cox, J.
;
Breen, M.
.
Value in Health. 21 (2018) - p. S459 , 2018
Link:
https://doi.org/10.1016/..
?
14
PCN276 - MANAGED ACCESS AGREEMENTS UNDER THE CANCER DRUGS F..:
Adler, B.
;
Privolnev, Y.
Value in Health. 21 (2018) - p. S61 , 2018
Link:
https://doi.org/10.1016/..
?
15
PUK26 - IMPACT OF EMERGING HIF-PH INHIBITORS ON RENAL ANEMI..:
Khan, J.
;
Blackstock, T.
;
Privolnev, Y.
.
Value in Health. 21 (2018) - p. S479 , 2018
Link:
https://doi.org/10.1016/..
1-15